Zheng, R., Yang, J., Wang, X., Jin, Y., Wang, Y., Su, W., . . . Xu, M. (2026). Tilianin Attenuates Myocardial Ischemia–Reperfusion Injury by Targeting RIP3-Mediated Necroptosis. Pharmaceuticals (14248247), 19(1), 84. https://doi.org/10.3390/ph19010084
Chicago Style (17th ed.) CitationZheng, Ruifang, et al. "Tilianin Attenuates Myocardial Ischemia–Reperfusion Injury by Targeting RIP3-Mediated Necroptosis." Pharmaceuticals (14248247) 19, no. 1 (2026): 84. https://doi.org/10.3390/ph19010084.
MLA (9th ed.) CitationZheng, Ruifang, et al. "Tilianin Attenuates Myocardial Ischemia–Reperfusion Injury by Targeting RIP3-Mediated Necroptosis." Pharmaceuticals (14248247), vol. 19, no. 1, 2026, p. 84, https://doi.org/10.3390/ph19010084.
Warning: These citations may not always be 100% accurate.